Investment trusts can often be tricky vehicles to understand because they have extra features over open-ended funds such as unit trusts and Oeics.

Being listed...

The announcement that Paul Polman is stepping down next year as chief executive (CEO) of consumer goods giant Unilever (ULVR) is significant for...

Clinigen (CLIN:AIM)

Gain to date: 0.1%

Original entry point: Buy at 865p, 11 October 2018

We...

We believe Schroder European Real Estate Investment Trust (SERE) is an excellent means of getting property exposure in your portfolio which is partly...

All of the headlines regarding to the UK stock market may well be dominated, in the short-term at least, by the result of the 11...

The final quarter of 2018 was shaping up to be a bruising period for investors as stocks drifted in September and then capitulated in October...

The UK’s biggest ever investment trust launch Smithson (SSON) has unveiled its top holdings and the stocks which have contributed to its performance...

Marlowe (MRL:AIM) 434p

Gain to date: 1.9%

Original entry point: Buy at 426p, 28 June 2018

The safety...

Pharmaceuticals giant GlaxoSmithKline (GSK) suffered a big fall in its share price on 3 December after announcing the $5.1bn acquisition of US cancer...

Stifel analyst Iain Scouller believes now is the time to buy investment trust Woodford Patient Capital Trust (WPCT), trading on a 13% discount to net...